DNA replication stress redistributes the histone methyltransferase G9a and activates lineage-specific gene expression
DNA replication stress triggers the WIZ-dependent redistribution of the repressive histone methyltransferase G9a from cis-regulatory elements to stalled replication forks, thereby relieving epigenetic silencing and activating lineage-specific gene expression programs such as fetal hemoglobin.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of a preprint that has not been peer-reviewed. It is not medical advice. Do not make health decisions based on this content. Read full disclaimer
Inside every living cell, the DNA that holds the blueprint for life must be copied perfectly every time the cell divides. This process is like a high-speed assembly line, but it is prone to jams. When the machinery that copies DNA slows down or gets stuck, it creates a state known as replication stress. While scientists have long known that this stress triggers emergency signals to fix the damage, a new study reveals a surprising side effect: this stress can also flip switches that turn specific genes on or off, changing the very identity of the cell. This is particularly important for understanding sickle cell disease, a painful blood disorder where a single genetic error causes red blood cells to become rigid and misshapen. A common drug used to treat this condition, hydroxyurea, works by inducing replication stress and reactivating a type of fetal hemoglobin that can bypass the defect. However, for decades, the exact mechanism by which this drug reactivates those beneficial genes remained a mystery.
Researchers at the Koch Institute for Integrative Cancer Research and other institutions set out to solve this puzzle using human red blood cell precursors. They discovered that when replication stress occurs, the cell does not just signal for repairs; it physically moves a key molecular tool away from its usual job. This tool is a protein complex called G9a, which normally acts as a silencer, keeping certain genes turned off by adding a chemical tag that makes the DNA inaccessible. The study found that when DNA copying stalls, these G9a silencers are pulled away from their target genes and dragged to the sites of the stalled machinery. Because the total amount of G9a in the cell is limited, this redistribution leaves the original target genes without their silencers. Without the silencer, these genes, which were previously locked down, become active.
In the specific case of red blood cells, one of the genes that gets unlocked is the one responsible for making fetal hemoglobin. Under normal conditions, this gene is silenced after birth, but the stress caused by hydroxyurea pulls the G9a silencer away, allowing the gene to turn back on. The researchers confirmed this by showing that when they artificially increased the amount of G9a in the cells, the drug lost its ability to reactivate the gene, proving that the drug works by depleting the local supply of the silencer. They also observed that this process is not random; the G9a complex is recruited to the stalled DNA sites by another protein called WIZ, which acts as a bridge. Without WIZ, the G9a silencers do not move to the stress sites, and the genes remain silent.
This discovery explains why hydroxyurea is effective for patients with sickle cell disease and suggests a broader principle for how cells adapt to stress. The study ruled out the idea that the drug works by simply damaging DNA or triggering a general stress alarm; instead, it works by hijacking the cell's epigenetic machinery. The researchers found that this redistribution of silencers does not require the cell to change its overall structure or become a different type of cell immediately; rather, it temporarily reprograms the cell's gene expression. This mechanism also helps explain why the drug works better in some patients than others, as the ability to reactivate the gene depends on the specific balance of these silencing proteins within each cell. By showing how a temporary jam in DNA copying can lead to a permanent change in gene activity, the study provides a clear, physical explanation for a decades-old medical mystery and offers a new perspective on how cells manage their genetic potential under pressure.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.